Flora Growth Corp. Further Growing its Market Reach with Recent Panama Entry

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

• Panama’s National Assembly recently passed a bill legalizing cannabis for medical use
• Plans are already in place to establish a technical council on cannabis, a national register of qualified users, and the issuance of seven licenses for import and domestic production of cannabis-based medicinal products
• Robust Farms Inc., a Panama-based importer and distributor, is set to receive its cannabis import license
• Flora has entered into a non-binding LOI with Robust to initially supply its premium CBD-derivative products from its Kasa Wholefoods division
• This marks a significant move in Flora’s overall global expansion plan

Years of research have shown that medical cannabis is helpful for pain control. It has also proven effective as a muscle relaxant, and it has even been shown to lessen tremors in Parkinson’s disease. Other ailments it has been known to manage include endometriosis, fibromyalgia, interstitial cystitis, and other conditions where the final common pathway is chronic pain (https://cnw.fm/951uH).

Governments worldwide are slowly warming up to the idea of legalizing cannabis for medical use, having weighed the pros and cons of such a move. In the United States, 18 states, and Washington, DC, have…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists, and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition, and brand awareness. CNW is where news, content, and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Image Sourced from Pixabay

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.